CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 19,920
+130 (0.66%)
Apr 24, 2026, 3:30 PM KST
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 109.28 billion as of April 24, 2026. Its market cap has increased by 0.15% in one year.
Market Cap
109.28B
Enterprise Value
n/a
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
19,920.00
Market Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 109.28B, an increase of 977.06%. That is a compound annual growth rate of 10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 109.28B | -2.11% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hana Pharm | 173.29B |
| Daihan Pharmaceutical | 171.11B |
| SAMSUNG PHARM. Co., LTD. | 170.92B |
| Dongwha Pharm.Co.,Ltd | 165.48B |
| Ilsung Is | 163.07B |
| Kyongbo Pharmaceutical | 161.85B |
| Jeil Pharma Holdings | 138.16B |
| HANDOK | 134.33B |